期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 16, 期 14, 页码 3684-3687出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2006.04.064
关键词
sphingosine-1-phosphate; S1P; immunosuppressant; lymphocyte-lowering; agonist; heteropentalene
Novel series of sphingosine-1-phosphate (S1P) receptor agonists were developed through a systematic SAR aimed to achieve high selectivity for a single member of the S1P family of receptors, S1P(1). The optimized structure represents a highly S1P(1)-selective and efficacious agonist: S1P(1)/S1P(2), S1P(1)/S1P(3), S1P(1)/S1P(4) > 10,000-fold, S1P(1)/S1P(5) > 600-fold, while EC50 (S1P(1)) < 0.2 nM. In vivo experiments are consistent with S1P(1) receptor agonism alone being sufficient for achieving desired lymphocyte-lowering effect. (c) 2006 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据